Table 2 Number of trials recording adverse events by type of treatment
Chemotherapy | Endocrine therapy | Radiotherapy | Neoadjuvant/perioperative therapy | Other | All | |
|---|---|---|---|---|---|---|
Cardiovascular | 3 (38%) | 4 (50%)* | 5 (71%)* | 0 (0%) | 2 (33%) | 14 (41%) |
Neurological | 1 (13%) | 2 (25%) | 0 (0%) | 0 (0%) | 2 (33%) | 5 (15%) |
Menopausal | 0 (0%) | 3 (38%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (9%) |
Fracture | 1 (13%) | 4 (50%)* | 5 (71%)* | 0 (0%) | 1 (17%) | 11 (32%) |
Other musculoskeletal | 1 (13%) | 4 (50%)* | 2 (29%) | 0 (0%) | 0 (0%) | 7 (21%) |
Psychiatric | 0 (0%) | 2 (25%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (6%) |
Gastrointestinal | 0 (0%) | 3 (38%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (9%) |
Gynaecological | 0 (0%) | 4 (50%)* | 0 (0%) | 0 (0%) | 0 (0%) | 4 (12%) |
Other (free text) | 6 (75%)* | 6 (75%)* | 5 (71%)* | 3 (60%)* | 4 (67%)* | 24 (71%)* |
Hospitalisations (free text) | 3 (38%) | 2 (25%) | 0 (0%) | 0 (0%) | 2 (33%) | 7 (21%) |